Subscribe To

Price Alert Latest News Economic Calendar News

AEMD / Aethlon Medical to Present at the 13th Annual LD Micro Invitational

SAN DIEGO , June 1, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectious diseases, today announced that Guy Cipriani, Senior Vice President and Chief Business Officer, and James Frakes, Chief Financial Officer, will present a company overview at the 13th Annual LD Micro Invitational on Wednesday, June 7, 2023, at 1:30 PM PT. Management will also be participating in one-on-one meetings with investors at this conference being held June 6-8, 2023, in Los Angeles, California. Read More

Demo Live Account See Partner Details

Content Topics

Aethlon

Medical

Present

13th

Annual

Micro

Invitational

Stock

AEMD

Posted: Jun 1 2023, 15:51

Author Name: PRNewsWire

AEMD News

By PRNewsWire
August 30, 2023

Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference

SAN DIEGO , Aug. 30, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat

By Seeking Alpha
August 10, 2023

Aethlon Medical, Inc. (AEMD) Q1 2024 Earnings Call Transcript

Aethlon Medical, Inc. (NASDAQ:AEMD ) Q1 2024 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Jim Frakes – Chief Financial O

By PRNewsWire
June 22, 2023

Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023

SAN DIEGO , June 22, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat

By PRNewsWire
June 1, 2023

Aethlon Medical to Present at the 13th Annual LD Micro Invitational

SAN DIEGO , June 1, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnos

By Seeking Alpha
February 13, 2023

Aethlon Medical, Inc. (AEMD) Q3 2023 Earnings Call Transcript

Aethlon Medical, Inc. (NASDAQ:AEMD ) Q3 2023 Earnings Conference Call February 13, 2023 4:30 PM ET Company Participants Jim Frakes - Chief Financial O

By PRNewsWire
February 6, 2023

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 13, 2023

SAN DIEGO , Feb. 6, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a company developing medical therapeutics to treat cancer and life-thre

By InvestorPlace
January 30, 2023

Why Is Aethlon Medical (AEMD) Stock Up 50% Today?

It's not every day that Aethlon Medical (NASDAQ: AEMD ) gets this much attention. AEMD stock is soaring today on unusually high volume.

By Seeking Alpha
November 14, 2022

Aethlon Medical, Inc. (AEMD) Q2 2022 Earnings Call Transcript

Aethlon Medical, Inc. (NASDAQ:AEMD ) Q2 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Charles Fisher - Chief Executi

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.